Extracellular superoxide dismutase in biology and medicine

Free Radical Biology and Medicine

Volumn 35, Issue 3, 2003, Pages 236-256

  Fattman, Cheryl L ^a   Schaefer, Lisa M ^a   Oury, Tim D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Extracellular superoxide dismutase; Free radicals; Neurological disease; Nitric oxide; Pulmonary disease; Superoxide

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

AGING; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN FUNCTION; BRAIN INJURY; BRAIN ISCHEMIA; CHROMOSOME 4Q; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME DENATURATION; ENZYME GLYCOSYLATION; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBUNIT; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FAMILIAL AMYLOID POLYNEUROPATHY; GENE LOCATION; GENE MAPPING; HEART MUSCLE REPERFUSION; HUMAN; HYDROPHOBICITY; HYPERTENSION; INFLAMMATORY INFILTRATE; LEARNING; LUNG DISEASE; LUNG FIBROSIS; LUNG INJURY; MEMORY; MOLECULAR WEIGHT; NEUROLOGIC DISEASE; NONHUMAN; OXYGEN TOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SPECIES DIFFERENCE; STRUCTURAL HOMOLOGY; VASCULAR SMOOTH MUSCLE;

EID: 0142012094     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00275-2     Document Type: Article

References (225)

1. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase a regulator of nitric oxide bioavailability . Lab. Invest. 75:1996;617-636.
2. Bowler R.P., Crapo J.D. Oxidative stress in airways is there a role for extracellular superoxide dismutase? Am. J. Respir. Crit. Care Med. 166:2002;S38-S43.
3. Delanty N., Dichter M.A. Oxidative injury in the nervous system. Acta Neurol. Scand. 98:1998;145-153.
4. Fukai T., Folz R.J., Landmesser U., Harrison D.G. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res. 55:2002;239-249.
5. McCord J.M. Human disease, free radicals, and the oxidant/antioxidant balance. Clin. Biochem. 26:1993;351-357.
6. McCord J.M., Fridovich I. Superoxide dismutase an enzymatic function for erythrocuprein (hemocuprein) . J. Biol. Chem. 244:1969;6049-6055.
7. Marklund S.L. Product of extracellular superoxide dismutase catalysis. FEBS Lett. 184:1985;237-239.
8. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA. 79:1982;7634-7638.
9. Forman H.J., Fridovich I. Superoxide dismutase a comparison of rate constants . Arch. Biochem. Biophys. 158:1973;396-400.
10. Weisiger R.A., Fridovich I. Mitochondrial superoxide simutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 248:1973;4793-4796.
11. Crapo J.D., Oury T., Rabouille C., Slot J.W., Chang L.Y. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA. 89:1992;10405-10409.
12. Oury T., Chang L.Y., Day B.J., Slot J.W., Crapo J. Compartmentialization of radical reactions. Davies K.J.A., Ursini F.S. The oxygen paradox. 1995;195-297 CLEUP University Press, Padova, Italy.
13. Slot J.W., Geuze H.J., Freeman B.A., Crapo J.D. Intracellular localization of the copper-zinc and manganese superoxide dismutases in rat liver parenchymal cells. Lab. Invest. 55:1986;363-371.
14. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Van der Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericak-Vance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., Brown R.H. Jr. Mutations in Cu,Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
15. Robinson B.H. The role of manganese superoxide dismutase in health and disease. J. Inherit. Metab. Dis. 21:1998;598-603.
16. Marklund S.L., Holme E., Hellner L. Superoxide dismutase in extracellular fluids. Clin. Chim. Acta. 126:1982;41-51.
17. Marklund S.L., Bjelle A., Elmqvist L.G. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann. Rheum. Dis. 45:1986;847-851.
18. Ookawara T., Kizaki T., Ohishi S., Yamamoto M., Matsubara O., Ohno H. Purification and subunit structure of extracellular superoxide dismutase from mouse lung tissue. Arch. Biochem. Biophys. 340:1997;299-304.
19. DiSilvestro R.A., Yang F.L., David E.A. Species-specific heterogeneity for molecular weight estimates of serum extracellular superoxide dismutase activities. Comp. Biochem. Physiol. B. 101:1992;531-534.
20. Oury T.D., Crapo J.D., Valnickova Z., Enghild J.J. Human extracellular superoxide dismutase is a tetramer composed of two disulphide-linked dimers a simplified, high-yield purification of extracellular superoxide dismutase . Biochem. J. 317:(Part 1):1996;51-57.
21. Fattman C.L., Enghild J.J., Crapo J.D., Schaefer L.M., Valnickova Z., Oury T.D. Purification and characterization of extracellular superoxide dismutase in mouse lung. Biochem. Biophys. Res. Commun. 275:2000;542-548.
22. Gerlach D., Reichardt W., Vettermann S. Extracellular superoxide dismutase from streptococcus pyogenes type 12 strain is manganese-dependent. FEMS Microbiol. Lett. 160:1998;217-224.
23. Stenlund P., Tibell L.A. Chimeras of human extracellular and intracellular superoxide dismutases. Analysis of structure and function of the individual domains. Protein Eng. 12:1999;319-325.
24. Tibell L.A., Skarfstad E., Jonsson B.H. Determination of the structural role of the n-terminal domain of human extracellular superoxide dismutase by use of protein fusions. Biochim. Biophys. Acta. 1292:1996;47-52.
25. Carlsson L.M., Marklund S.L., Edlund T. The rat extracellular superoxide dismutase dimer is converted to a tetramer by the exchange of a single amino acid. Proc. Natl. Acad. Sci. USA. 93:1996;5219-5222.
26. Tibell L., Hjalmarsson K., Edlund T., Skogman G., Engstrom A., Marklund S.L. Expression of human extracellular superoxide dismutase in chinese hamster ovary cells and characterization of the product. Proc. Natl. Acad. Sci. USA. 84:1987;6634-6638.
27. Marklund S.L. Properties of extracellular superoxide dismutase from human lung. Biochem. J. 220:1984;269-272.
28. Tibell L., Aasa R., Marklund S.L. Spectral and physical properties of human extracellular superoxide dismutase a comparison with Cu,Zn superoxide dismutase . Arch. Biochem. Biophys. 304:1993;429-433.
29. Hendrickson D.J., Fisher J.H., Jones C., Ho Y.S. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics. 8:1990;736-738.
30. Gallagher D.S. Jr., Gibbs L.S., Shaffer J.B., Womack J.E. Somatic cell mapping of bovine EC-SOD and sod1l loci. Genomics. 12:1992;610-612.
31. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family A comparison of the Cu,ZnSOD (sod1), MnSOD (sod2), and EC-SOD (sod3) gene structures, evolution, and expression . Free Radic. Biol. Med. 33:2002;337-349.
32. Ho Y.S., Howard A.J., Crapo J.D. Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am. J. Respir. Cell Mol. Biol. 4:1991;278-286.
33. Folz R.J., Crapo J.D. Extracellular superoxide dismutase (sod3) tissue-specific expression, genomic characterization, and computer-assisted sequence analysis of the human EC-SOD gene . Genomics. 22:1994;162-171.
34. Bowler R.P., Arcaroli J., Crapo J.D., Ross A., Slot J.W., Abraham E. Extracellular superoxide dismutase attenuates lung injury after hemorrhage. Am. J. Respir. Crit. Care Med. 164:2001;290-294.
35. Ookawara T., Imazeki N., Matsubara O., Kizaki T., Oh-Ishi S., Nakao C., Sato Y., Ohno H. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am. J. Physiol. 275:1998;C840-C847.
36. Hjalmarsson K., Marklund S.L., Engstrom A., Edlund T. Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc. Natl. Acad. Sci. USA. 84:1987;6340-6344.
37. Perry A.C.F., Jones R., Hall L. Isolation and characterization of a rat cDNA clone encoding a secreted superoxide dismutase reveals the epididymis to be a major site of its expression. Biochem. J. 293:1993;21-25.
38. Willems J., Zwijsen A., Slegers H., Nicolai S., Bettadapura J., Raymackers J., Scarcez T. Purification and sequence of rat extracellular superoxide dismutase b secreted by c6 glioma. J. Biol. Chem. 268:1993;24614-24621.
39. Folz R.J., Guan J., Seldin M.F., Oury T.D., Enghild J.J., Crapo J.D. Mouse extracellular superoxide dismutase primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization . Am. J. Respir. Cell Mol. Biol. 17:1997;393-403.
40. Laukkanen M.O., Mannermaa S., Hiltunen M.O., Aittomaki S., Airenne K., Janne J., Yla-Herttuala S. Local hypomethylation in atherosclerosis found in rabbit EC-SOD gene. Arterioscler. Thromb. Vasc. Biol. 19:1999;2171-2178.
41. Stromqvist M., Holgersson J., Samuelsson B. Glycosylation of extracellular superoxide dismutase studied by high-performance liquid chromatography and mass spectrometry. J. Chromatogr. 548:1991;293-301.
42. Edlund A., Edlund T., Hjalmarsson K., Marklund S.L., Sandstrom J., Stromqvist M., Tibell L. A nonglycosylated extracellular superoxide dismutase variant. Biochem. J. 288:(Part 2):1992;451-456.
43. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 222:1984;649-655.
44. Marklund S.L. Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74:1984;1398-1403.
45. Behndig A., Svensson B., Marklund S.L., Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest. Ophthalmol. Vis. Sci. 39:1998;471-475.
46. Williams K., Frayne J., McLaughlin E.A., Hall L. Expression of extracellular superoxide dismutase in the human male reproductive tract, detected using antisera raised against a recombinant protein. Mol. Hum. Reprod. 4:1998;235-242.
47. Marklund S.L. Expression of extracellular superoxide dismutase by human cell lines. Biochem. J. 266:1990;213-219.
48. Lookene A., Stenlund P., Tibell L.A. Characterization of heparin binding of human extracellular superoxide dismutase. Biochemistry. 39:2000;230-236.
49. Sandstrom J., Carlsson L., Marklund S.L., Edlund T. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J. Biol. Chem. 267:1992;18205-18209.
50. Adachi T., Kodera T., Ohta H., Hayashi K., Hirano K. The heparin binding site of human extracellular superoxide dismutase. Arch. Biochem. Biophys. 297:1992;155-161.
51. Ohta H., Adachi T., Hirano K. The nature of heterogeneous components of extracellular superoxide dismutase purified from human umbilical cords. Free Radic. Biol. Med. 15:1993;151-158.
52. Tibell L.A., Sethson I., Buevich A.V. Characterization of the heparin-binding domain of human extracellular superoxide dismutase. Biochim. Biophys. Acta. 1340:1997;21-32.
53. Karlsson K., Lindahl U., Marklund S.L. Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem. J. 256:1988;29-33.
54. Adachi T., Marklund S.L. Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides. J. Biol. Chem. 264:1989;8537-8541.
55. Marklund S.L. Analysis of extracellular superoxide dismutase in tissue homogenates and extracellular fluids. Methods Enzymol. 186:1990;260-265.
56. Karlsson K., Marklund S.L. Extracellular superoxide dismutase in the vascular system of mammals. Biochem. J. 255:1988;223-228.
57. Sandstrom J., Karlsson K., Edlund T., Marklund S.L. Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem. J. 294:(Part 3):1993;853-857.
58. Adachi T., Yamada H., Futenma A., Kato K., Hirano K. Heparin-induced release of extracellular superoxide dismutase form (v) to plasma. J. Biochem. (Tokyo). 117:1995;586-590.
59. Karlsson K., Marklund S.L. Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem. J. 242:1987;55-59.
60. Karlsson K., Marklund S.L. Heparin-, dextran sulfate-, and protamine-induced release of extracellular superoxide dismutase to plasma in pigs. Biochim. Biophys. Acta. 967:1988;110-114.
61. Karlsson K., Marklund S.L. Plasma clearance of human extracellular superoxide dismutase C in rabbits. J. Clin. Invest. 82:1988;762-766.
62. Karlsson K., Marklund S.L. Binding of human extracellular superoxide dismutase C to cultured cell lines and to blood cells. Lab. Invest. 60:1989;659-666.
63. Karlsson K., Edlund A., Sandstrom J., Marklund S.L. Proteolytic modification of the heparin-binding affinity of extracellular superoxide dismutase. Biochem. J. 290:(Part 2):1993;623-626.
64. McCord J.M., Gao B., Leff J., Flores S.C. Neutrophil-generated free radicals possible mechanisms of injury in adult respiratory distress syndrome . Environ. Health Perspect. 102:(Suppl. 10):1994;57-60.
65. Enghild J.J., Thogersen I.B., Oury T.D., Valnickova Z., Hojrup P., Crapo J.D. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J. Biol. Chem. 274:1999;14818-14822.
66. Bowler R.P., Nicks M., Olsen D.A., Thogersen I.B., Valnickova Z., Hojrup P., Franzusoff A., Enghild J.J., Crapo J.D. Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase. J. Biol. Chem. 277:2002;16505-16511.
67. Karlsson K., Sandstrom J., Edlund A., Marklund S.L. Turnover of extracellular superoxide dismutase in tissues. Lab. Invest. 70:1994;705-710.
68. Ookawara T., Kizaki T., Takayama E., Imazeki N., Matsubara O., Ikeda Y., Suzuki K., Li Ji L., Tadakuma T., Taniguchi N., Ohno H. Nuclear translocation of extracellular superoxide dismutase. Biochem. Biophys. Res. Commun. 296:2002;54-61.
69. Adachi T., Hara H., Yamada H., Yamazaki N., Yamamoto M., Sugiyama T., Futenma A., Katagiri Y. Heparin-stimulated expression of extracellular superoxide dismutase in human fibroblasts. Atherosclerosis. 159:2001;307-312.
70. Stralin P., Marklund S.L. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis. 151:2000;433-441.
71. Brady T.C., Chang L.Y., Day B.J., Crapo J.D. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation. Am. J. Physiol. 273:1997;L1002-L1006.
72. Mruk D., Cheng C.H., Cheng Y.H., Mo M.Y., Grima J., Silvestrini B., Lee W.M., Cheng C.Y. Rat testicular extracellular superoxide dismutase its purification, cellular distribution, and regulation . Biol. Reprod. 59:1998;298-308.
73. Mruk D.D., Cheng C.Y. In vitro regulation of extracellular superoxide dismutase in sertoli cells. Life Sci. 67:2000;133-145.
74. Adachi T., Yamada H., Hara H., Futenma A., Kakumu S. Increase of urinary extracellular superoxide dismutase level correlated with cyclic adenosine monophosphate. FEBS Lett. 458:1999;370-374.
75. Stralin P., Marklund S.L. Effects of oxidative stress on expression of extracellular superoxide dismutase, Cu,Zn superoxide dismutase, and Mn superoxide dismutase in human dermal fibroblasts. Biochem. J. 298:(Part 2):1994;347-352.
76. Olin K.L., Golub M.S., Gershwin M.E., Hendrickx A.G., Lonnerdal B., Keen C.L. Extracellular superoxide dismutase activity is affected by dietary zinc intake in nonhuman primate and rodent models. Am. J. Clin. Nutr. 61:1995;1263-1267.
77. Oteiza P.I., Adonaylo V.N., Keen C.L. Cadmium-induced testes oxidative damage in rats can be influenced by dietary zinc intake. Toxicology. 137:1999;13-22.
78. Davis C.D., Milne D.B., Nielsen F.H. Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am. J. Clin. Nutr. 71:2000;781-788.
79. Adachi T., Ohta H., Yamada H., Futenma A., Kato K., Hirano K. Quantitative analysis of extracellular superoxide dismutase in serum and urine by ELISA with monoclonal antibody. Clin. Chim. Acta. 212:1992;89-102.
80. Adachi T., Nakamura M., Yamada H., Kitano M., Futenma A., Kato K., Hirano K. Pedigree of serum extracellular superoxide dismutase level. Clin. Chim. Acta. 223:1993;185-187.
81. Sandstrom J., Nilsson P., Karlsson K., Marklund S.L. Ten-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J. Biol. Chem. 269:1994;19163-19166.
82. Adachi T., Yamada H., Yamada Y., Morihara N., Yamazaki N., Murakami T., Futenma A., Kato K., Hirano K. Substitution of glycine for arginine-213 in extracellular superoxide dismutase impairs affinity for heparin and endothelial cell surface. Biochem. J. 313:(Part 1):1996;235-239.
83. Yamada H., Yamada Y., Adachi T., Fukatsu A., Sakuma M., Futenma A., Kakumu S. Protective role of extracellular superoxide dismutase in hemodialysis patients. Nephron. 84:2000;218-223.
84. Marklund S.L., Nilsson P., Israelsson K., Schampi I., Peltonen M., Asplund K. Two variants of extracellular superoxide dismutase relationship to cardiovascular risk factors in an unselected middle-aged population . J. Intern. Med. 242:1997;5-14.
85. Adachi T., Morihara N., Yamazaki N., Yamada H., Futenma A., Kato K., Hirano K. An arginine-213 to glycine mutation in human extracellular superoxide dismutase reduces susceptibility to trypsin-like proteinases. J. Biochem. (Tokyo). 120:1996;184-188.
86. Yamada H., Yamada Y., Adachi T., Goto H., Ogasawara N., Futenma A., Kitano M., Miyai H., Fukatsu A., Hirano K., Kakumu S. Polymorphism of extracellular superoxide dismutase (EC-SOD) gene relation to the mutation responsible for high EC-SOD level in serum . Jpn. J. Hum. Genet. 42:1997;353-356.
87. Oury T.D., Chang L.Y., Marklund S.L., Day B.J., Crapo J.D. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab. Invest. 70:1994;889-898.
88. Stralin P., Karlsson K., Johansson B.O., Marklund S.L. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler. Thromb. Vasc. Biol. 15:1995;2032-2036.
89. Oury T.D., Day B.J., Crapo J.D. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic. Biol. Med. 20:1996;957-965.
90. Stralin P., Marklund S.L. Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H1621-H1629.
91. Ohta H., Adachi T., Hirano K. Internalization of human extracellular superoxide dismutase by bovine aortic endothelial cells. Free Radic. Biol. Med. 16:1994;501-507.
92. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
93. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369:1995;39-48.
94. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91:1993;2546-2551.
95. Mugge A., Brandes R.P., Boger R.H., Dwenger A., Bode-Boger S., Kienke S., Frolich J.C., Lichtlen P.R. Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 24:1994;994-998.
96. White C.R., Brock T.A., Chang L.Y., Crapo J., Briscoe P., Ku D., Bradley W.A., Gianturco S.H., Gore J., Freeman B.A., Tarpey M.M. Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA. 91:1994;1044-1048.
97. Landmesser U., Merten R., Spiekermann S., Buttner K., Drexler H., Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease relation to endothelium-dependent vasodilation . Circulation. 101:2000;2264-2270.
98. Takatsu H., Tasaki H., Kim H.N., Ueda S., Tsutsui M., Yamashita K., Toyokawa T., Morimoto Y., Nakashima Y., Adachi T. Overexpression of EC-SOD suppresses endothelial cell-mediated LDL oxidation. Biochem. Biophys. Res. Commun. 285:2001;84-91.
99. Fukai T., Galis Z.S., Meng X.P., Parthasarathy S., Harrison D.G. Vascular expression of extracellular superoxide dismutase in atherosclerosis. J. Clin. Invest. 101:1998;2101-2111.
100. Luoma J.S., Stralin P., Marklund S.L., Hiltunen T.P., Sarkioja T., Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins . Arterioscler. Thromb. Vasc. Biol. 18:1998;157-167.
101. Sentman M.L., Brannstrom T., Westerlund S., Laukkanen M.O., Yla-Herttuala S., Basu S., Marklund S.L. Extracellular superoxide dismutase deficiency and atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;1477-1482.
102. Wilcken D.E., Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J. Clin. Invest. 57:1976;1079-1082.
103. Dudman N.P., Wilcken D.E., Wang J., Lynch J.F., Macey D., Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler. Thromb. 13:1993;1253-1260.
104. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med. 337:1997;230-236.
105. Wall R.T., Harlan J.M., Harker L.A., Striker G.E. Homocysteine-induced endothelial cell injury in vitro a model for the study of vascular injury . Thromb. Res. 18:1980;113-121.
106. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98:1996;5-7.
107. Wang X.L., Duarte N., Cai H., Adachi T., Sim A.S., Cranney G., Wilcken D.E. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors, and coronary artery disease in the Australian hospital-based population. Atherosclerosis. 146:1999;133-140.
108. Wilcken D.E., Wang X.L., Adachi T., Hara H., Duarte N., Green K., Wilcken B. Relationship between homocysteine and superoxide dismutase in homocystinuria possible relevance to cardiovascular risk . Arterioscler. Thromb. Vasc. Biol. 20:2000;1199-1202.
109. Wang X.L., Adachi T., Sim A.S., Wilcken D.E. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18:1998;1915-1921.
110. Yamamoto M., Hara H., Adachi T. Effects of homocysteine on the binding of extracellular superoxide dismutase to the endothelial cell surface. FEBS Lett. 486:2000;159-162.
111. Nonaka H., Tsujino T., Watari Y., Emoto N., Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine amelioration of homocysteine-induced endoplasmic reticulum stress by taurine . Circulation. 104:2001;1165-1170.
112. Griendling K.K., Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 91:2000;21-27.
113. Laursen J.B., Rajagopalan S., Galis Z., Tarpey M., Freeman B.A., Harrison D.G. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 95:1997;588-593.
114. Fukai T., Siegfried M.R., Ushio-Fukai M., Griendling K.K., Harrison D.G. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ. Res. 85:1999;23-28.
115. Hornig B., Landmesser U., Kohler C., Ahlersmann D., Spiekermann S., Christoph A., Tatge H., Drexler H. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease role of superoxide dismutase . Circulation. 103:2001;799-805.
116. Adachi T., Ohta H., Hayashi K., Hirano K., Marklund S.L. The site of nonenzymic glycation of human extracellular superoxide dismutase in vitro. Free Radic. Biol. Med. 13:1992;205-210.
117. Adachi T., Ohta H., Hirano K., Hayashi K., Marklund S.L. Nonenzymic glycation of human extracellular superoxide dismutase. Biochem. J. 279:(Part I):1991;263-267.
118. Adachi T., Nakamura M., Yamada H., Futenma A., Kato K., Hirano K. Quantitative and qualitative changes of extracellular superoxide dismutase in patients with various diseases. Clin. Chim. Acta. 229:1994;123-131.
119. Sentman M.L., Jonsson L.M., Marklund S.L. Enhanced alloxan-induced β-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 27:1999;790-796.
120. Taniguchi N. Superoxide dismutases significances in aging, diabetes, ischemia and cancer . Rinsho Byori. 38:1990;876-881.
121. Kawamura N., Ookawara T., Suzuki K., Konishi K., Mino M., Taniguchi N. Increased glycated Cu,Zn superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetis mellitus. J. Clin. Endocrinol. Metab. 74:1992;1352-1354.
122. Oda A., Bannai C., Yamaoka T., Katori T., Matsushima T., Yamashita K. Inactivation of Cu,Zn superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm. Metab. Res. 26:1994;1-4.
123. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products a mechanism for accelerated atherogenesis in diabetes . Biochem. Biophys. Res. Commun. 173:1990;932-939.
124. Ookawara T., Matsuura N., Oh-ishi T., Okazaki M., Kizaki T., Suzuki K., Hitomi Y., Ohno H. Serum extracellular superoxide dismutase in pediatric patients with various diseases as judged by an ELISA. Res. Commun. Mol. Pathol. Pharmacol. 107:2000;291-296.
125. Marklund S.L., Hagglof B. Plasma EC-superoxide dismutase activity in insulin-dependent diabetic children. Clin. Chim. Acta. 142:1984;299-305.
126. Dhalla N.S., Elmoselhi A.B., Hata T., Makino N. Status of myocardial antioxidants in ischemia/reperfusion injury. Cardiovasc. Res. 47:2000;446-456.
127. Hatori N., Sjoquist P.O., Marklund S.L., Pehrsson S.K., Ryden L. Effects of recombinant human extracellular superoxide dismutase type C on myocardial reperfusion injury in isolated cold-arrested rat hearts. Free Radic. Biol. Med. 13:1992;137-142.
128. Sjoquist P.O., Carlsson L., Jonason G., Marklund S.L., Abrahamsson T. Cardioprotective effects of recombinant human extracellular superoxide dismutase type C in rat isolated heart subjected to ischemia and reperfusion. J. Cardiovasc. Pharmacol. 17:1991;678-683.
129. Sjoquist P.O., Marklund S.L. Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischemic rat hearts. Cardiovasc. Res. 26:1992;347-350.
130. Pisarenko O.I., Studneva I.M., Lakomkin V.L., Timoshin A.A., Kapelko V.I. Human recombinant extracellular superoxide dismutase type C improves cardioplegic protection against ischemia/reperfusion injury in isolated rat heart. J. Cardiovasc. Pharmacol. 24:1994;655-663.
131. Johansson M.H., Deinum J., Marklund S.L., Sjoquist P.O. Recombinant human extracellular superoxide dismutase reduces concentration of oxygen free radicals in the reperfused rat heart. Cardiovasc. Res. 24:1990;500-503.
132. Hatori N., Sjoquist P.O., Marklund S.L., Ryden L. Effects of recombinant human extracellular superoxide dismutase type C on myocardial infarct size in pigs. Free Radic. Biol. Med. 13:1992;221-230.
133. Chen E.P., Bittner H.B., Davis R.D., Folz R.J., Van Trigt P. Extracellular superoxide dismutase transgene overexpression preserves postischemic myocardial function in isolated murine hearts. Circulation. 94:1996;II412-II417.
134. Chen E.P., Bittner H.B., Davis R.D., Van Trigt P., Folz R.J. Physiologic effects of extracellular superoxide dismutase transgene overexpression on myocardial function after ischemia and reperfusion injury. J. Thorac. Cardiovasc. Surg. 115:1998;450-459.
135. Li Q., Bolli R., Qiu Y., Tang X.L., Murphree S.S., French B.A. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation. 98:1998;1438-1448.
136. Li Q., Bolli R., Qiu Y., Tang X.L., Guo Y., French B.A. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation. 103:2001;1893-1898.
137. Nilsson U.A., Haraldsson G., Bratell S., Sorensen V., Akerlund S., Pettersson S., Schersten T., Jonsson O. ESR measurement of oxygen radicals in vivo after renal ischemia in the rabbit. Effects of pretreatment with superoxide dismutase and heparin. Acta Physiol. Scand. 147:1993;263-270.
138. Erlansson M., Bergqvist D., Marklund S.L., Persson N.H., Svensjo E. Superoxide dismutase as an inhibitor of postischemic microvascular permeability increase in the hamster. Free Radic. Biol. Med. 9:1990;59-65.
139. • a pulse radiolysis study . Free Radic. Biol. Med. 19:1995;505-510.
140. Kobayashi S., Imajoh-Ohmi S., Kuribayashi F., Nunoi H., Nakamura M., Kanegasaki S. Characterization of the superoxide-generating system in human peripheral lymphocytes and lymphoid cell lines. J. Biochem. (Tokyo). 117:1995;758-765.
141. Abrahamsson T., Brandt U., Marklund S.L., Sjoqvist P.O. Vascular bound recombinant extracellular superoxide dismutase type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ. Res. 70:1992;264-271.
142. Gielen S., Schuler G., Hambrecht R. Exercise training in coronary artery disease and coronary vasomotion. Circulation. 103:2001;E1-E6.
143. Fukai T., Siegfried M.R., Ushio-Fukai M., Cheng Y., Kojda G., Harrison D.G. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J. Clin. Invest. 105:2000;1631-1639.
144. Adachi T., Wang X.L. Association of extracellular superoxide dismutase phenotype with the endothelial constitutive nitric oxide synthase polymorphism. FEBS Lett. 433:1998;166-168.
145. Yamamoto M., Hara H., Adachi T. Nitric oxide and its decomposed derivatives decrease the binding of extracellular superoxide dismutase to the endothelial cell surface. FEBS Lett. 505:2001;296-300.
146. Vilar R.E., Ghael D., Li M., Bhagat D.D., Arrigo L.M., Cowman M.K., Dweck H.S., Rosenfeld L. Nitric oxide degradation of heparin and heparan sulphate. Biochem. J. 324:(Part 2):1997;473-479.
147. Kulich S.M., Chu C.T. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine implications for Parkinson's disease . J. Neurochem. 77:2001;1058-1066.
148. Oury T.D., Card J.P., Klann E. Localization of extracellular superoxide dismutase in adult mouse brain. Brain Res. 850:1999;96-103.
149. Nicolai S., Willems J., Zwijsen A., Van Mechelen E., Slegers H. Cyclic amp-induced differentiation increases the synthesis of extracellular superoxide dismutase in rat c6 glioma. Free Radic. Biol. Med. 21:1996;481-486.
150. Ohe Y., Ishikawa K., Itoh Z., Tatemoto K. Cultured leptomeningeal cells secrete cerebrospinal fluid proteins. J. Neurochem. 67:1996;964-971.
151. Hurd R.W., Wilder B.J., Helveston W.R., Uthman B.M. Treatment of four siblings with progressive myoclonus epilepsy of the unverricht-lundborg type with n-acetylcysteine. Neurology. 47:1996;1264-1268.
152. Levin E.D., Brucato F.H., Crapo J.D. Molecular overexpression of extracellular superoxide dismutase increases the dependency of learning and memory performance on motivational state. Behav. Genet. 30:2000;95-100.
153. Levin E.D., Brady T.C., Hochrein E.C., Oury T.D., Jonsson L.M., Marklund S.L., Crapo J.D. Molecular manipulations of extracellular superoxide dismutase functional importance for learning . Behav. Genet. 28:1998;381-390.
154. Thiels E., Urban N.N., Gonzalez-Burgos G.R., Kanterewicz B.I., Barrionuevo G., Chu C.T., Oury T.D., Klann E. Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 20:2000;7631-7639.
155. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21:2001;2-14.
156. Sheng H., Bart R.D., Oury T.D., Pearlstein R.D., Crapo J.D., Warner D.S. Mice overexpressing extracellular superoxide dismutase have increased resistance to focal cerebral ischemia. Neuroscience. 88:1999;185-191.
157. Sheng H., Brady T.C., Pearlstein R.D., Crapo J.D., Warner D.S. Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse. Neurosci. Lett. 267:1999;13-16.
158. Sheng H., Kudo M., Mackensen G.B., Pearlstein R.D., Crapo J.D., Warner D.S. Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. Exp. Neurol. 163:2000;392-398.
159. Fukui S., Ookawara T., Nawashiro H., Suzuki K., Shima K. Postischemic transcriptional and translational responses of EC-SOD in mouse brain and serum. Free Radic. Biol. Med. 32:2002;289-298.
160. Demchenko I.T., Oury T.D., Crapo J.D., Piantadosi C.A. Regulation of the brain's vascular responses to oxygen. Circ. Res. 91:2002;1031-1037.
161. McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., Graham D.I. Neuropathological sequelae of traumatic brain injury relationship to neurochemical and biomechanical mechanisms . Lab. Invest. 74:1996;315-342.
162. Kontos H.A., Wei E.P. Superoxide production in experimental brain injury. J. Neurosurg. 64:1986;803-807.
163. Kontos H.A. Oxygen radicals in CNS damage. Chem. Biol. Interact. 72:1989;229-255.
164. Crow J.P., Beckman J.S. The importance of superoxide in nitric oxide-dependent toxicity evidence for peroxynitrite-mediated injury . Adv. Exp. Med. Biol. 387:1996;147-161.
165. Pineda J.A., Aono M., Sheng H., Lynch J., Wellons J.C., Laskowitz D.T., Pearlstein R.D., Bowler R., Crapo J., Warner D.S. Extracellular superoxide
166. Oury T.D., Piantadosi C.A., Crapo J.D. Cold-induced brain edema in mice. Involvement of extracellular superoxide dismutase and nitric oxide. J. Biol. Chem. 268:1993;15394-15398.
167. Sakashita N., Ando Y., Marklund S.L., Nilsson P., Tashima K., Yamashita T., Takahashi K. Familial amyloidotic polyneuropathy type 1 with extracellular superoxide dismutase mutation a case report . Hum. Pathol. 29:1998;1169-1172.
168. 2 toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;9715-9719.
169. Shingu M., Todoroki T., Nobunaga M. Generation of superoxide by immunologically stimulated normal human neutrophils and possible modulation by intracellular and extracellular SOD and rheumatoid factors. Inflammation. 11:1987;143-151.
170. Fattman C.L., Chu C.T., Kulich S.M., Enghild J.J., Oury T.D. Altered expression of extracellular superoxide dismutase in mouse lung after bleomycin treatment. Free Radic. Biol. Med. 31:2001;1198-1207.
171. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
172. Nozik-Grayck E., Dieterle C.S., Piantadosi C.A., Enghild J.J., Oury T.D. Secretion of extracellular superoxide dismutase in neonatal lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L977-L984.
173. Boggess K.A., Oury T.D., Kay H.H., Crapo J.D. Extracellular superoxide dismutase localization and activity within the human placenta. Placenta. 19:1998;417-422.
174. Boggess K.A., Kay H.H., Crapo J.D., Moore W.F., Suliman H.B., Oury T.D. Differential localization of placental extracellular superoxide dismutase as pregnancy progresses. Am. J. Obstet. Gynecol. 183:2000;199-205.
175. Adachi T., Masuda K., Hara H., Yamamoto M., Mitsui N., Oh-ishi T., Okazaki M. Plasma extracellular superoxide dismutase in healthy newborns and infants/children. Clin. Chim. Acta. 295:2000;203-205.
176. Adachi T., Yamamoto M., Hara H., Masuda K., Mitsui N., Oh-ishi T., Okazaki M. Extracellular superoxide dismutase in cerebrospinal fluid from infants/children. Clin. Chim. Acta. 308:2001;191-193.
177. Adachi T., Wang J., Wang X.L. Age-related change of plasma extracellular superoxide dismutase. Clin. Chim. Acta. 290:2000;169-178.
178. Su W.Y., Folz R., Chen J.S., Crapo J.D., Chang L.Y. Extracellular superoxide dismutase mRNA expressions in the human lung by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 16:1997;162-170.
179. Loenders B., Van Mechelen E., Nicolai S., Buyssens N., Van Osselaer N., Jorens P.G., Willems J., Herman A.G., Slegers H. Localization of extracellular superoxide dismutase in rat lung neutrophils and macrophages as carriers of the enzyme . Free Radic. Biol. Med. 24:1998;1097-1106.
180. Wispe J.R., Warner B.B., Clark J.C., Dey C.R., Neuman J., Glasser S.W., Crapo J.D., Chang L.Y., Whitsett J.A. Human Mn superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J. Biol. Chem. 267:1992;23937-23941.
181. Welty-Wolf K.E., Simonson S.G., Huang Y.C., Kantrow S.P., Carraway M.S., Chang L.Y., Crapo J.D., Piantadosi C.A. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J. Appl. Physiol. 83:1997;559-568.
182. Simonson S.G., Welty-Wolf K.E., Huang Y.C., Taylor D.E., Kantrow S.P., Carraway M.S., Crapo J.D., Piantadosi C.A. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. I. Physiology and biochemistry. J. Appl. Physiol. 83:1997;550-558.
183. Fan J., Shek P.N., Suntres Z.E., Li Y.H., Oreopoulos G.D., Rotstein O.D. Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery. 128:2000;332-338.
184. Walther F.J., Nunez F.L., David-Cu R., Hill K.E. Mitigation of pulmonary oxygen toxicity in rats by intratracheal instillation of polyethylene glycol-conjugated antioxidant enzymes. Pediatr. Res. 33:1993;332-335.
185. Carlsson L.M., Jonsson J., Edlund T., Marklund S.L. Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc. Natl. Acad. Sci. USA. 92:1995;6264-6268.
186. Folz R.J., Abushamaa A.M., Suliman H.B. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J. Clin. Invest. 103:1999;1055-1066.
187. Christner P., Fein A., Goldberg S., Lippmann M., Abrams W., Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 131:1985;690-695.
188. Pardo A., Selman M., Ridge K., Barrios R., Sznajder J.I. Increased expression of gelatinases and collagenase in rat lungs exposed to 100% oxygen. Am. J. Respir. Crit. Care Med. 154:1996;1067-1075.
189. Torii K., Iida K., Miyazaki Y., Saga S., Kondoh Y., Taniguchi H., Taki F., Takagi K., Matsuyama M., Suzuki R. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:1997;43-46.
190. Oury T.D., Schaefer L.M., Fattman C.L., Choi A., Weck K.E., Watkins S.C. Depletion of pulmonary EC-SOD after exposure to hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:2002;L777-L784.
191. Tate R.M., Repine J.E. Neutrophils and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 128:1983;552-559.
192. Adamson I.Y., Bowden D.H. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 77:1974;185-197.
193. Fasske E., Morgenroth K. Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis. Lung. 161:1983;133-146.
194. Bowler R.P., Nicks M., Warnick K., Crapo J.D. Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:2002;L719-L726.
195. Bowler R., Russell P., Nicks M., Crapo J. Mice overexpressing extracellular superoxide dismutase are resistant to bleomycin-induced pulmonary injury. Chest. 120:2001;10S.
196. Ledwozyw A. Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. II. Phospholipids of the lung surfactant. Acta Physiol. Hung. 78:1991;157-162.
197. Parizada B., Werber M.M., Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic. Res. Commun. 15:1991;297-301.
198. Yamazaki C., Hoshino J., Hori Y., Sekiguchi T., Miyauchi S., Mizuno S., Horie K. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice. Jpn. J. Pharmacol. 75:1997;97-100.
199. Oury T.D., Thakker K., Menache M., Chang L.Y., Crapo J.D., Day B.J. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am. J. Respir. Cell Mol. Biol. 25:2001;164-169.
200. Marklund S.L. Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. J. Biol. Chem. 267:1992;6696-6701.
201. Suliman H.B., Ryan L.K., Bishop L., Folz R.J. Prevention of influenza-induced lung injury in mice overexpressing extracellular superoxide dismutase. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L69-L78.
202. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation the cytotoxic potential of superoxide and nitric oxide . Arch. Biochem. Biophys. 288:1991;481-487.
203. Moreno J.J., Pryor W.A. Inactivation of α1-proteinase inhibitor by peroxynitrite. Chem. Res. Toxicol. 5:1992;425-431.
204. Haddad I.Y., Ischiropoulos H., Holm B.A., Beckman J.S., Baker J.R., Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265:1993;L555-L564.
205. Ghio A.J., Suliman H.B., Carter J.D., Abushamaa A.M., Folz R.J. Overexpression of extracellular superoxide dismutase decreases lung injury after exposure to oil fly ash. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:2002;L211-L218.
206. Zuo L., Christofi F.L., Wright V.P., Liu C.Y., Merola A.J., Berliner L.J., Clanton T.L. Intra- and extracellular measurement of reactive oxygen species produced during heat stress in diaphragm muscle. Am. J. Physiol. Cell Physiol. 279:2000;C1058-C1066.
207. Monboisse J.C., Braquet P., Randoux A., Borel J.P. Nonenzymatic degradation of acid-soluble calf skin collagen by superoxide ion protective effect of flavonoids . Biochem. Pharmacol. 32:1983;53-58.
208. Monboisse J.C., Bellon G., Dufer J., Randoux A., Borel J.P. Collagen activates superoxide anion production by human polymorphonuclear neutrophils. Biochem. J. 246:1987;599-603.
209. Burkhardt H., Hartmann F., Schwingel M.L. Activation of latent collagenase from polymorphonuclear leukocytes by oxygen radicals. Enzyme. 36:1986;221-231.
210. Sorsa T., Saari H., Konttinen Y.T., Suomalainen K., Lindy S., Uitto V.J. Nonproteolytic activation of latent human neutrophil collagenase and its role in matrix destruction in periodontal diseases. Int. J. Tissue React. 11:1989;153-159.
211. Monboisse J.C., Bellon G., Randoux A., Dufer J., Borel J.P. Activation of human neutrophils by type 1 collagen. Requirement of two different sequences. Biochem. J. 270:1990;459-462.
212. Stromqvist M., Houdebine M., Andersson J.O., Edlund A., Johansson T., Viglietta C., Puissant C., Hansson L. Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res. 6:1997;271-278.
213. Hansson L., Edlund M., Edlund A., Johansson T., Marklund S.L., Fromm S., Stromqvist M., Tornell J. Expression and characterization of biologically active human extracellular superoxide dismutase in milk of transgenic mice. J. Biol. Chem. 269:1994;5358-5363.
214. Karlsson K., Sandstrom J., Edlund A., Edlund T., Marklund S.L. Pharmacokinetics of extracellular superoxide dismutase in the vascular system. Free Radic. Biol. Med. 14:1993;185-190.
215. Laukkanen M.O., Lehtolainen P., Turunen P., Aittomaki S., Oikari P., Marklund S.L., Yla-Herttuala S. Rabbit extracellular superoxide dismutase expression and effect on LDL oxidation . Gene. 254:2000;173-179.
216. Iyama S., Okamoto T., Sato T., Yamauchi N., Sato Y., Sasaki K., Takahashi M., Tanaka M., Adachi T., Kogawa K., Kato J., Sakamaki S., Niitsu Y. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum. 44:2001;2160-2167.
217. Laukkanen M.O., Leppanen P., Turunen P., Tuomisto T., Naarala J., Yla-Herttuala S. EC-SOD gene therapy reduces paracetamol-induced liver damage in mice. J. Gene Med. 3:2001;321-325.
218. Nakane H., Chu Y., Faraci F.M., Oberley L.W., Heistad D.D. Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid. Stroke. 32:2001;184-189.
219. Patel M., Day B.J. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol. Sci. 20:1999;359-364.
220. Chang L.Y., Crapo J.D. Inhibition of airway inflammation and hyperreactivity by an antioxidant mimetic. Free Radic. Biol. Med. 33:2002;379-386.
221. Smith K.R., Uyeminami D.L., Kodavanti U.P., Crapo J.D., Chang L.Y., Pinkerton K.E. Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant. Free Radic. Biol. Med. 33:2002;1106-1114.
222. Mackensen G.B., Patel M., Sheng H., Calvi C.L., Batinic-Haberle I., Day B.J., Liang L.P., Fridovich I., Crapo J.D., Pearlstein R.D., Warner D.S. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. J. Neurosci. 21:2001;4582-4592.
223. Bowler R.P., Sheng H., Enghild J.J., Pearlstein R.D., Warner D.S., Crapo J.D. A catalytic antioxidant (aeol 10150) attenuates expression of inflammatory genes in stroke. Free Radic. Biol. Med. 33:2002;1141-1152.
224. Sheng H., Enghild J.J., Bowler R., Patel M., Batinic-Haberle I., Calvi C.L., Day B.J., Pearlstein R.D., Crapo J., Warner D.S. Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia. Free Radic. Biol. Med. 33:2002;947-961.
225. Day B.J., Crapo J.D. A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced lung injury in vivo. Toxicol. Appl. Pharmacol. 140:1996;94-100.